Deutsche Bank Ag\ Aclaris Therapeutics, Inc. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Aclaris Therapeutics, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 923,313 shares of ACRS stock, worth $2.68 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

923,313

Previous 923,313 -0.0%

Holding current value

$2.68 Million

Previous $1.02 Million 2.76%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$1.01 - $1.36 $34,045 - $45,842	-33,708 Reduced 3.52%	923,313 $1.02 Million
Q1 2024 May 15, 2024	BUY	$0.92 - $1.44 $21,137 - $33,084	22,975 Added 2.46%	957,021 $1.19 Million
Q4 2023 Feb 14, 2024	BUY	$0.64 - $6.49 $499,031 - $5.06 Million	779,737 Added 505.31%	934,046 $980,000
Q3 2023 Nov 09, 2023	SELL	$6.56 - $10.95 $6.12 Million - $10.2 Million	-932,311 Reduced 85.8%	154,309 $1.06 Million
Q2 2023 Aug 14, 2023	SELL	$7.89 - $10.64 $122,902 - $165,739	-15,577 Reduced 1.41%	1,086,620 $11.3 Million
Q1 2023 May 15, 2023	SELL	$7.07 - $17.95 $533,049 - $1.35 Million	-75,396 Reduced 6.4%	1,102,197 $8.92 Million
Q4 2022 Feb 13, 2023	BUY	$14.33 - $18.37 $124,613 - $159,745	8,696 Added 0.74%	1,177,593 $18.5 Million
Q3 2022 Nov 14, 2022	SELL	$13.07 - $18.22 $75,858 - $105,748	-5,804 Reduced 0.49%	1,168,897 $18.4 Million
Q2 2022 Aug 11, 2022	SELL	$10.16 - $17.08 $2.97 Million - $4.99 Million	-292,402 Reduced 19.93%	1,174,701 $16.4 Million
Q1 2022 May 13, 2022	BUY	$9.74 - $17.92 $11.8 Million - $21.7 Million	1,213,032 Added 477.44%	1,467,103 $25.3 Million
Q4 2021 Feb 11, 2022	SELL	$12.27 - $18.49 $838,875 - $1.26 Million	-68,368 Reduced 21.2%	254,071 $3.69 Million
Q3 2021 Nov 04, 2021	SELL	$13.38 - $18.8 $157,817 - $221,746	-11,795 Reduced 3.53%	322,439 $5.8 Million
Q2 2021 Aug 11, 2021	BUY	$17.08 - $29.6 $1.29 Million - $2.24 Million	75,523 Added 29.19%	334,234 $5.87 Million
Q1 2021 May 13, 2021	BUY	$5.86 - $27.73 $1.13 Million - $5.35 Million	193,083 Added 294.21%	258,711 $6.52 Million
Q2 2020 Aug 13, 2020	BUY	$1.04 - $1.73 $27,669 - $46,026	26,605 Added 68.18%	65,628 $106,000
Q1 2020 May 14, 2020	SELL	$0.75 - $2.18 $471 - $1,369	-628 Reduced 1.58%	39,023 $41,000
Q4 2019 Feb 14, 2020	BUY	$1.02 - $1.97 $30,979 - $59,832	30,372 Added 327.32%	39,651 $73,000
Q3 2019 Nov 14, 2019	SELL	$0.79 - $2.47 $351,305 - $1.1 Million	-444,690 Reduced 97.96%	9,279 $9,000
Q2 2019 Aug 14, 2019	BUY	$2.13 - $7.06 $780,768 - $2.59 Million	366,558 Added 419.35%	453,969 $992,000
Q1 2019 May 15, 2019	BUY	$5.63 - $7.84 $155,123 - $216,015	27,553 Added 46.03%	87,411 $522,000
Q4 2018 Feb 14, 2019	SELL	$6.3 - $15.4 $1.66 Million - $4.06 Million	-263,723 Reduced 81.5%	59,858 $442,000
Q3 2018 Dec 21, 2021	BUY	$14.38 - $20.89 $596,597 - $866,684	41,488 Added 14.71%	323,581 $4.7 Million
Q3 2018 Nov 14, 2018	BUY	$14.38 - $20.89 $759,522 - $1.1 Million	52,818 Added 23.04%	282,093 $4.1 Million
Q2 2018 Apr 21, 2020	BUY	$16.46 - $20.33 $1.54 Million - $1.91 Million	93,707 Added 69.12%	229,275 $4.58 Million
Q2 2018 Aug 14, 2018	BUY	$16.46 - $20.33 $628,228 - $775,935	38,167 Added 39.19%	135,568 $2.71 Million
Q1 2018 Oct 18, 2019	BUY	$17.08 - $25.64 $1.21 Million - $1.82 Million	71,111 Added 270.49%	97,401 $1.71 Million
Q1 2018 May 15, 2018	SELL	$17.08 - $25.64 $2.62 Million - $3.93 Million	-153,332 Reduced 85.36%	26,290 $459,000
Q4 2017 Feb 14, 2018	BUY	$21.47 - $27.8 $875,632 - $1.13 Million	40,784 Added 29.38%	179,622 $4.43 Million
Q3 2017 Nov 14, 2017	BUY	$23.02 - $28.8 $3.2 Million - $4 Million	138,838	138,838 $3.58 Million

Others Institutions Holding ACRS

# of Institutions

Shares Held

50.7M

Call Options Held

30.6K

Put Options Held

View Full List

About Aclaris Therapeutics, Inc.

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $193M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

More about ACRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account